Isolation, activation, polarisation and killing — the four steps where T-cell experiments usually succeed or fail, with the format and the readout chosen together.
T cells are the most forgiving population to isolate and the least forgiving to activate. Negative selection keeps the TCR untouched; CD3/CD28 beads replace feeder cells; polarisation conditions decide the subset; and the killing assay decides whether any of it meant anything.
T lymphocytes mature in the thymus and carry a clonotypic TCR that reads peptide presented on MHC. This overview covers thymic selection and repertoire construction, the three-signal model of activation, effector subset division of labour and immunological memory.
Read the protocolNegative selection leaves the target T cells untouched by bead and antibody, which is why it is the default for functional work. The protocol runs from sample preparation through column-free isolation to CD3/CD28 activation, for both human PBMC and mouse spleen.
Read the protocolCFSE dilution halves the dye with every division, producing the staircase of peaks used to reconstruct proliferation history. The protocol combines column-free isolation with bead activation and covers labelling through to peak readout.
Read the protocolRegulatory T cells are defined by CD4⁺CD25⁺FoxP3⁺ and act as the negative control arm of immune tolerance. Covers Treg biology, the three requirements for in vitro induction, and how to verify suppressive function rather than only FoxP3 percentage.
Read the protocolTh1 cells are marked by IFN-γ secretion and defined by the transcription factor T-bet, and they drive cell-mediated immunity against intracellular pathogens and tumours. Covers the polarisation signalling and the readouts that confirm it.
Read the protocolTh2 cells are marked by IL-4, IL-5 and IL-13 and governed by GATA3; they mediate humoral immunity, anti-parasite responses and allergic inflammation. Covers the polarisation protocol and the verification strategy.
Read the protocolFrom scFv discovery and screening through CAR–antigen affinity measurement and transmembrane or intracellular domain customisation, to target-cell preparation and in vitro and in vivo verification — the six stages of CAR development and the control point in each.
Read the protocolThe classical in vitro model for CAR-T function: effectors co-cultured with antigen-positive tumour cells across an effector-to-target gradient, quantified by luciferase, LDH release or flow-based apoptosis staining, with an antigen-negative control for specificity.
Read the protocolA TCR-dependent model that does not require a CAR: antigen-specific (OT-1) or polyclonally activated CD8⁺ CTLs co-cultured with tumour cells, read for killing and cytokine release. The standard tool for tumour immunogenicity and immune-drug screening.
Read the protocolWhen the experiment needs T cells removed rather than recovered — enriching non-T populations, building an immunodeficient background, or modelling GVHD in vitro — a biotinylated antibody plus streptavidin bead workflow removes CD3, CD4 or CD8 positive cells.
Read the protocolThe catalogue numbers used in these protocols, all with a numbered manual and lot-level COA.
10 protocols in this category. Each one opens with the starting material and closes with the readout that proves the population is what you think it is.
Tell us your cell type, sample source and downstream assay — we will suggest an isolation route, a culture condition and the matching catalogue numbers.